[NEW EBOOK] Safety Assessment for Ophthalmic Products


Excellence in Ophthalmic Safety Testing

Altasciences has been conducting ophthalmic safety testing for decades, with all global regulatory submissions from our studies approved for design, conduct, and data integrity. We perform ocular pharmacokinetic studies in multiple species (rodent and non-rodent), using different types of formulations and routes of administration, and support study durations ranging from single-dose acute to studies of six and nine months.

Learn more about our early phase ophthalmic drug development expertise in our latest eBook.

Do you have an ocular drug compound in your development pipeline?
Speak with one of our experts about your study or end-to-end, preclinical to clinical proof-of-concept program. Let’s get you started!

Related resources that may interest you:

The Altascientist: The Complexities of Early Phase Ophthalmic Drug Development
Fact Sheet: Comprehensive Services for Ophthalmic Drug Development